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Whitney M.L. Limm MD, MaryS. Wheeler MSN, *Sara lshimoto RN, 
*Mary O'Friel MHSA, and Alan H.S. Cheung MD 
Donor organ availability is the primary limiting factor in organ 
transplantation. The number of patients on the national organ 
waitlist has increased to more than 32,000, while the number of 
donors has remained fairly constant at approximately 4,500 per 
year. In Hawaii, there are 98 patients awaiting organ transplants, 
and for the past 5 years, the average number of donors per year 
was 15. The criteria for organ donation, brain death, approaches 
to donation request, and the management of the multiple organ 
donor are discussed. 
Introduction 
The field of organ transplantation has made remarkable 
progress in recent years. Advancements in tissue typing, surgi-
cal techniques and im-
munosuppression have 
increased by only 11%.2 Because the number of organ donors 
has not increased in proportion to the waitlist, waitlist mortality 
is increasing. One estimate is that 38% of patients awaiting 
heart, lung, or 1i ver transplantation die before an organ becomes 
available. 3 
In Hawaii there are 98 patients on the transplant waitlist 
(Table 1). Many patients have been on the list for several years 
as the state averages less than 20 donors a year. 
Nationally, the reasons for the shortage of organ donors 
include: 1) The family is approached and declines permission, 2) 
organ donation is not considered after the diagnosis of brain 
death has been made, 3) a failure to identify brain death, and 4) 
poor organ perfusion through donor instability. When the family 
is approached and consent 
is declined, the following 
resulted in enhanced 1-
year patient survival rates 
for kidney, heart, pan-
creas, and liver trans-
plants. The advances in 
the field and resultant 
successes have led to a 
steady increase in the 
number of patients seek-
ingtransplants. The num-
ber of year-end registra-
tions has been increasing 
since 1988, with annual 
increases ranging from 
12% to 19%. 1 Overall 
registration on the United 
Organ Sharing Network 
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The aim of this study 
was to examine the char-
acteristics of the actual 
donors in Hawaii and com-
pare them to national sta-
tistics. Discussion will be 
focused on the need to in-
crease both the local and 
national donor pools, an 
explanation ofbrain death, 
FIQ 1.--A comparison of the number and type of organs recovered In Hawaii for the 
past 5 years. 
approaches to donation 
request, and management 
of donors prior to organ 
(UN OS) waitlist has increased by 81% between 1988 and 1991.1 
This increase in the number of patients on the waitlist has not 
been matched by an increase in the number of organ donors. 
From 1988 to 1991, the total number of cadaveric donors 
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procurement. 
Methods 
The Organ Donor Center of Hawaii is a non-profit organiza-
tion devoted to coordination of organ donation in Hawaii. It also 
educates the medical community and the general public about 
the importance of organ donation. This organization, like the 65 
other organ procurement organizations in the United States, is 
funded by Medicare and private insurance. 
A retrospective analysis was performed on all organ donors 
in Hawaii using records from the Organ DonorCenterofHawaii. 
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To develop a profile of the donors in Hawaii, the following 
information was obtained for each patient: Age, sex, cause of 
death, ethnicity, hospital where donation originated, and organs 
donated. 
Results 
Over a 5-yearperiod from January 1, 1989 to December 31, 
1993, 75 organ donors were recorded in Hawaii. Table 2 
indicates the number and age distribution of donors per year. The 
average age was 31; local donors reflected the national statistics 
in that a majority were from the 19 to 35 age group. Seventy-five 
percent of local donors were male; this majority was consistent 
with the national data (61.5%).2 Over 50% of the local donors 
were Caucasian, with Japanese, Chinese and Filipino minorities 
represented (Table 3). 
For organ donors in Hawaii, motor vehicle accidents were the 
most common cause of death. Nationally, this cause is ranked 
behind cerebrovascular accidents, which is thought to be due to 
improvements in the care of trauma patients and passage of 
safety laws governing the use of seatbelts and motorcycle 
helmets;2 perhaps the higher ranking locally reflected the ab-
sence of mandatory helmet laws for motorcycle riders. Locally, 
other causes of death included cerebrovascular accidents, gun-
shot wounds, asphyxiation and drowning (Table 4). 
Thirty of the donors were hospitalized at The Queen's Medi-
cal Center, where a large number of trauma patients are treated. 
As a result of advances in organ procurement and storage, 
hospitals on Neighbor Islands contributed to the donor pool 
(Table 5). 
In the early stages of this review, only kidneys and hearts were 
recovered for transplantation. In 1991 the first liver was recov-
ered; the first liver recovered and transplanted in Hawaii oc-
curred in 1993. Another landmark in local medical history also 
occurred 1993 when the first pancreas was recovered and 
successfully transplanted (Fig 1). 
Discussion 
The biggest obstacle facing organ transplantation is the 
limited number of organ donors. It is estimated there are between 
4,992 and 28,954 potential cadaveric organ donors nationally 
each year.4 The actual number of donors, however, has been 
fairlyconstant, with4,516donorsin 1991.2 0verthepast5years, 
the state of Hawaii has averaged 15 donors per million of 
population a year. This is below the national average of 18 
donors per million of population a year. 
Criteria for organ donation 
Organ donation should be considered when a patient is 
admitted with a life threatening or irreversible brain injury. The 
Organ Donor Center of Hawaii should be notified when a 
diagnosis of brain death is anticipated or has been made. Follow-
ing declaration of brain death, consent for organ donation is 
obtained from the next of kin. Regardless of the patient's 
signature on a donor card or driver's license, no organs are 
removed without this consent. The involvement of the donation 
coordinator at this stage is crucial; these highly trainedindividu-
-
als can give families a clear and objective understanding of 
organ donation. Concerns regarding respect for the body and 
preservation of dignity, along with questions regarding funeral 
arrangements and viewing are of utmost importance to the 
grieving family. Donation coordinators are available 24-hours a 
day to assist the families, physicians and hospital staff through-
out the donation process. 
The ideal cadaveric donor is a previously healthy individual 
whose death is caused by an isolated, irreversible brain injury.5 
To be considered, adequate circulation and oxygenation to the 
organs must be maintained. Absolute contraindications to organ 
donation are: Non-CNS malignancy, active infection (bacterial, 
fungal, viral, parasitic), or seropositivity for hepatitis, HIV, and 
HTL V -1. The upper age limit for organ donation is increasing; 
in Hawaii, liver and kidneys from donors as old as 66 years of age 
with adequate physiologic function have been removed for 
transplantation. The generally accepted upper age limit for heart 
donation in Hawaii is 45 years of age. 
Brain death 
Brain death is required prior to cadaveric organ donation. The 
specific criteria for brain death was initially addressed by the 
Harvard Commission in 1968, with other studies following.6 
Currently, all 50 states have laws recognizing brain death.5 The 
current guidelines for determination of brain death are summa-
rized in Table 6. In Hawaii, declaration of brain death by 2 
physicians is required; one of the physicians usually is a neurolo-
gist or a neurosurgeon and neither physician may be a member 
of the transplant team. 
After metabolic factors have been corrected, tests are admin-
istered to determine cessation of cerebral and brain stem activ-
ity. While the law permits declaration of brain death by clinical 
examination alone, confirmatory tests such as an EEG or a 
nuclear medicine brain flow study may be performed. 
A brain dead patient is legally dead. This concept may be 
difficult for the public to grasp and is important to consider when 
discussing the timing of the request for organ donation. Families 
should not be approached about organ donation until after they 
have been told their loved one is brain dead and all questions are 
answered about this diagnosis. This concept is known as 
decoupling. After the families have had the chance to accept 
brain death as final and to grieve over the loss of their loved one, 
then the option of organ donation can be presented. Research has 
shown that by using the decoupling process, the consent rate 
from families nearly doubled.7 
Donor management 
If there are no contraindications to organ donation after the 
medical history is reviewed, the functional status of the various 
organs is evaluated with blood tests and hemodynamic monitor-
ing. The brain dead patient is often hemodynamically unstable 
during the evaluation process. To ensure adequate perfusion of 
the organs, a central venous catheter or Swan Ganz catheter and 
a Foley catheter often are necessary to guide fluid management. 
The goal is to maintain normal or near normal oxygenation and 
perfusion of the organs being considered for transplantation. 
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Table 1 Patients on Transplant Waitlist 
in Hawaii 
As of November 24, 1993 
Kidney 90 Heart 4 Liver 3 Pancreas 1 
Total 98 
Table 2 Donors by Age And Year in Hawaii 
(1989 to 1993) 
Age Bracket 1989 1990 1991 1992 1993 
Oto5 2 
6to 18 4 2 5 3 
19 to 35 5 6 8 10 5 
36 to 49 3 4 4 3 2 
50 to 64 5 
>65 
Total 
Donors a year 12 12 13 25 13 
Table 3 Donors by Ethnicity in Hawaii 
(1989 to 1993) 
Caucasian 44 (58%) 
Japanese 8 (11%) 
Chinese 4 (5%) 
Filipino ':! (4%) 
" 
Local mix 5 (7%) 
Other 11 (15%) 
Total 75 (100%) 
Table 4 Donors by Cause of Death in Hawaii 
(1989 to 1993) 
Motorcycle/Car 23 (31%) 
Cerebrovascular 19 (25%) 
Gunshot 9 (12%) 
Other head trauma 11 (14%) 
Asphyxiation 2 (3%) 
Drowning 3 (4%) 
Other 8 (11%) 
Table 5 Donors by Hospital in Hawaii 
(1989 to 1993) 
Hospital Number of Donors 
The Queen's Medical Center 30 
Kapiolani Medical Center 7 
Straub Clinic and Hospital 7 
Kaiser Permanente Medical Care Program 6 
Tripier Army Medical Center 6 
Maui Memorial Hospital 5 
Castle Medical Center 4 
Hilo Hospital 3 
Kapiolani Medical Center at Pali Momi 3 
St. Francis Medical Center 2 
Kuakini Medical Center 1 
Wilcox Memorial Hospital 1 
Total 75 
Table 6 Guidelines for Determination of Death 
• Established in the absence of complicating metabolic factors, 
drug overdose, altered electrolyte, acid-base or glucose 
homeostasis, hypothermia (<32.2° C), or shock 
• Etiology established, recovery excluded, persists on 
repeated examination 
Neurologic Death 
• Deep coma, cerebral unresponsiveness and unreceptivity 
Absence of brain stem functions 
• No spontaneous respirations (apnea in the setting of hypercarbia) 
• Reflexes are all absent: Pupillary light, oculocephalic (doll's eyes), 
oculovestibular (cold water calories), oropharyngeal (gag), respiratory, 
and corneal 
Cardiopulmonary Death 
• Irreversible cessation of circulatory and respiratory functions 
-
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Over70% of organ donors require treatment for diabetes insipidus 
and Pitressin is the most commonly used agent for this condi-
tion. Electrolytes are monitored frequently and corrected as 
needed.7•8 
When the blood test results are deemed acceptable, the patient 
is then taken to the operating room. The organs are perfused with 
cold preservation solutions prior to surgical removal; this is 
referred to as core-cooling. This is done by placing catheters in 
the infrarenal aorta and vena cava. s Surgical removal of multiple 
organs follows this sequence: Heart, liver, pancreas, and kid-
neys.5 
Once removed, the preservation of the organ can be pro-
longed using hypothermia either by means of simple cold 
storage or with a hypothermic pulsatile perfusion machine.5 
With the use of preservation solutions and either hypothermic 
technique, a heart can be preserved for 5 hours, liver and 
pancreas up to 24 hours, and a kidney up to 48 hours after 
removal. 
Summary 
Organ transplantation, both locally and nationally, is limited 
by the lack of organ donors. This review of the proflle of local 
organ donors revealed similar demographic information when 
compared to national statistics. In an effort to alleviate the organ 
shortage in Hawaii, the past 5 years showed an increase in the 
types of organs obtained for transplantation. In addition, organs 
from older donors are being transplanted. Further study is 
needed to determine the barriers to organ donation. Once iden-
tified, and appropriate action initiated, it is hoped that the 
number of transplants will increase and the waitlist mortality can 
be minimized through maximizing organ recovery. 
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